Beloqui A - Search Results

1

Barriers to the Intestinal Absorption of Four Insulin-Loaded Arginine-Rich Nanoparticles in Human and Rat.

Lundquist P, Khodus G, Niu Z, Thwala LN, McCartney F, Simoff I, Andersson E, Beloqui A, Mabondzo A, Robla S, Webb DL, Hellström PM, Keita ÅV, Sima E, Csaba N, Sundbom M, Preat V, Brayden DJ, Alonso MJ, Artursson P. Lundquist P, et al. Among authors: beloqui a. ACS Nano. 2022 Sep 27;16(9):14210-14229. doi: 10.1021/acsnano.2c04330. Epub 2022 Aug 23. ACS Nano. 2022. PMID: 35998570 Free PMC article.

2

Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier.

Beloqui A, Solinís MÁ, Gascón AR, del Pozo-Rodríguez A, des Rieux A, Préat V. Beloqui A, et al. J Control Release. 2013 Mar 10;166(2):115-23. doi: 10.1016/j.jconrel.2012.12.021. Epub 2012 Dec 22. J Control Release. 2013. PMID: 23266764

3

Dextran-protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugs.

Beloqui A, Solinís MÁ, des Rieux A, Préat V, Rodríguez-Gascón A. Beloqui A, et al. Int J Pharm. 2014 Jul 1;468(1-2):105-11. doi: 10.1016/j.ijpharm.2014.04.027. Epub 2014 Apr 16. Int J Pharm. 2014. PMID: 24746410

4

pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease.

Beloqui A, Coco R, Memvanga PB, Ucakar B, des Rieux A, Préat V. Beloqui A, et al. Int J Pharm. 2014 Oct 1;473(1-2):203-12. doi: 10.1016/j.ijpharm.2014.07.009. Epub 2014 Jul 8. Int J Pharm. 2014. PMID: 25014369

5

Nanostructured lipid carriers: Promising drug delivery systems for future clinics.

Beloqui A, Solinís MÁ, Rodríguez-Gascón A, Almeida AJ, Préat V. Beloqui A, et al. Nanomedicine. 2016 Jan;12(1):143-61. doi: 10.1016/j.nano.2015.09.004. Epub 2015 Sep 26. Nanomedicine. 2016. PMID: 26410277 Review.

6

Delivery of Peptides Via the Oral Route: Diabetes Treatment by Peptide-Loaded Nanoparticles.

Bouttefeux O, Beloqui A, Preat V. Bouttefeux O, et al. Among authors: beloqui a. Curr Pharm Des. 2016;22(9):1161-76. doi: 10.2174/1381612822666151216150238. Curr Pharm Des. 2016. PMID: 26675223 Review.

7

Nanoparticle transport across in vitro olfactory cell monolayers.

Gartziandia O, Egusquiaguirre SP, Bianco J, Pedraz JL, Igartua M, Hernandez RM, Préat V, Beloqui A. Gartziandia O, et al. Among authors: beloqui a. Int J Pharm. 2016 Feb 29;499(1-2):81-89. doi: 10.1016/j.ijpharm.2015.12.046. Epub 2015 Dec 22. Int J Pharm. 2016. PMID: 26721725

8

Reformulating cyclosporine A (CsA): More than just a life cycle management strategy.

Guada M, Beloqui A, Kumar MN, Préat V, Dios-Viéitez Mdel C, Blanco-Prieto MJ. Guada M, et al. Among authors: beloqui a. J Control Release. 2016 Mar 10;225:269-82. doi: 10.1016/j.jconrel.2016.01.056. Epub 2016 Jan 30. J Control Release. 2016. PMID: 26829101 Review.

9

Targeting Inflammatory Bowel Diseases by Nanocarriers Loaded with Small and Biopharmaceutical Anti-Inflammatory Drugs.

Beloqui A, Coco R, Préat V. Beloqui A, et al. Curr Pharm Des. 2016;22(40):6192-6206. doi: 10.2174/1381612822666160211141813. Curr Pharm Des. 2016. PMID: 26864312 Review.

10

Cyclosporine A-loaded lipid nanoparticles in inflammatory bowel disease.

Guada M, Beloqui A, Alhouayek M, Muccioli GG, Dios-Viéitez Mdel C, Préat V, Blanco-Prieto MJ. Guada M, et al. Among authors: beloqui a. Int J Pharm. 2016 Apr 30;503(1-2):196-8. doi: 10.1016/j.ijpharm.2016.03.012. Epub 2016 Mar 10. Int J Pharm. 2016. PMID: 26972380

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page